Article Are Monoclonal Antibodies the Future of Long COVID Treatments? Dr. Nancy Klimas, director of the Institute for Neuro-Immune Medicine at Nova Southeastern University, explains the great potential of monoclonal antibodies in treating long COVID.

Press/Media: Research

Period	Apr 23 2024

Media coverage

Title	Article Are Monoclonal Antibodies the Future of Long COVID Treatments? Dr. Nancy Klimas, director of the Institute for Neuro-Immune Medicine at Nova Southeastern University, explains the great potential of monoclonal antibodies in treating long COVID.
Media name/outlet	Technology Networks
Country/Territory	United Kingdom
Date	4/23/24
URL	https://www.technologynetworks.com/tn/articles/are-monoclonal-antibodies-the-future-of-long-covid-treatments-386038
Persons	Nancy G Klimas